Antimicrobial resistance challenge requests to be able to measure patient medication-adherence in outpatient setting, where more than 90% of antibiotics are prescribed. We take advantage of an original dataset where adherence to treatment has been measured through two alternative measurements: pills count and the Morisky scale. Considering the first measure as benchmark, we test the validity of each of the Morisky items and their composition in a synthetic scale. We show that the short-form version of the medication-adherence scale with three items has the best predictive properties in the domain of antibiotic treatments. Given its concision, this tool could even be used by clinicians to quickly assess patients' adherence and modify it in the course, when needed. 
Introduction
A dherence to antibiotic treatments is an important issue both for the patient herself as well as for the whole society knowing the considerable challenge of bacterial resistance. 1 One crucial point is to be able to measure patient medication-adherence in outpatient setting, where more than 90% of antibiotics are prescribed. 2 Among the few available, a study in Portugal 3 has found an adherence of only 55%, which demonstrates the necessity to scrutinize this patient's misbehaviour, with the best detection tools available.
The Morisky scale is a recognized tool to assess patients' adherence in outpatient setting by questionnaire. The Morisky scale has been developed for chronic treatment in 1986, to study the case of medication adherence in hypertension treatments. 4 To date, various versions of this scale exist, extending its utilization to other chronic conditions. 5, 6 Yet, the Morisky scale has not been validated in the case of acute disease, despite its effective use to assess adherence to antibiotics. 3 We take advantage of an original dataset where adherence to antibiotic (ATB) treatments has been measured through two alternative measurements: pills count and the Morisky scale. We consider pills count remaining at the end of the treatment as our benchmark and investigate (1) whether the Morisky scale predicts correctly adherence-behaviour for the case of ATB treatment; (2) which items of the Morisky scale are really accurate. We attempt to propose a combination of items which better replicates the result obtained with the pills count.
Methods

Sample
At the occasion of an experimental study testing the feasibility of delivering ATB treatments out of their pre-packed box in France, we considered 848 adult-patients who received the exact number of pills prescribed. 64% are women, they have on average 54 years old, 53% of them are married and 50% are workers or office employees.
Adherence benchmark
Respondents were interviewed 2 days after the end of their treatment. They were firstly asked about the number of pills they have left. Given that, by construction of the study, patients had received the exact number of prescribed pills, individuals who declare a residual can be identified as 'non-adherent'. We consider this measure as our benchmark.
Survey adherence measure
The self-reported measure of adherence to treatment was based on the four-item scale developed by Morisky et al. 4 , with one additional item which captures the difficulties in remembering to take the antibiotics. Table 1 presents the five items used in this study and recalls the source literature. In multi-item scales, patients were defined as non-adherent when answering positively to at least one item.
Following Refs. [4] and [6] , we look at the external validity of the self-reported adherence scale. We first test the reliability of each item of the scale (table 1) . We also test different definitions of medication-adherence made of various combinations of the five items available in the questionnaire. The positive and negative predictive values, the sensitivity and specificity rates as well as the Youden index provide criterions to determine which index approaches the most our benchmark.
Results
Using the five-item scale, the Morisky-scale gives 78% of adherence. In a quite similar disease context (accurate disease treated by antibiotics), but not in the same country and probably not on the same population in terms of age and sex characteristics (given that the list of antibiotics was wider), Fernandes et al. 3 found 55% of adherence, using a slightly distinct five-item scale. We observe that this rate departs from the 91% adherence rate obtained in the benchmark (see Supplementary table S1 for a basic description of adherent vs. non-adherent populations). To investigate further the external validity of the Morisky scale, we first consider each item alone: item 3 and item 4 are those which perform better regarding the specificity dimensions, followed by item 1, but all have a weak sensitivity when used alone (0.32 for the best one). Notes: Sample, 848 observations; Positive predictive value, fraction of patients classified as non-adherent with at least one residual pill left; Negative predictive value, fraction of patients classified as adherent with zero residual pills; Sensitivity, fraction of patients with at least one residual pill who will be classified as non-adherent; Specificity, fraction of patients with zero residual pill who will be classified as adherent; Youden index, Sensitivity + Specificity À 1.
Mixed together, these three items along with item 5 are the ones which compose the basic 1986 Morisky scale. Given the respective values of the sensitivity and specificity indexes, we find out that the three-item Morisky-scale composed of the items 1, 3 and 4 has the higher Youden index. This primary superiority of the three-item scale is reinforced when considering the positive and negative predictive values (PPV, NPV). We also tested a less stringent definition of adherence for the benchmark, hypothesizing that we could accept a 'one-day tolerance' in residuals counting. Results remain very similar, with Youden indexes of 0.55 (three-item), 0.52 (four-item), 0.50 (five-item scale).
Discussion
The observation of the sensitivity and specificity indexes and the synthetic Youden index pushes to validate the three-item Morisky scale in this specific context of acute treatments in an outpatient setting. In another context (hypertension treatment), Morisky et al. 6 used an eight-item scale and compare it with a blood pressure benchmark. Using their best detection tool based on an eight-item scale, the authors found a Youden index of 0.46, to be compared to our Youden indexes, ranging from 0.55 for three-item to 0.49 for the five-item scale. The combination of more than 3 items does not seem to produce a better accuracy of the scale-leading to a weak improvement of the sensitivity rate but at the cost of substantial decrease in specificity. Therefore, we validate the prior intuition that Morisky scale also supports ATB treatment, proposed by Ref. [3] , and determine that the three-item version is the best option in this case.
A crucial element in this statement is the confidence we can put in the benchmark we used. Although the number of pills left is selfreported by the patient, we reduced potential desirability bias by introducing this question at the very beginning of the questionnaire. At that point, individuals expect to be asked about the drug's delivery mode, which was the object of the experiment, 7 and not their treatment adherence.
To conclude, the shorter version of the Morisky scale including three items is valid for measuring adherence to antibiotic treatments. Given its shortness, this version of the scale can even be used, by caregivers, to early detect patients' adherence failures, for a rapid intervention aiming at improving this adherence. It could participate to the fight against one important dimension of ATB misuse in the community.
